LG Life Science to develop vaccines for bovine mastitis

Published: 2005-08-16 06:59:00

Updated: 2005-08-16 06:59:00

LG Life Science has succeeded in developing a vaccine for the bovine mastitis through a gene recombinant technology first in Korea.

LG Life Science developed the bovine mastitis vaccine for the milk cows by using attenuated SEC, an enterotoxin of staphylococci originated from Idaho, U. S. A an...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK